[Studies on the effects of antituberculosis agents against tubercle bacilli in the resting state, using streptomycin-dependent strain (18-b). II. Studies in vivo].
D000818:Animals; D000995:Antitubercular Agents / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D004977:Ethambutol / Q000627:therapeutic use; D007538:Isoniazid / Q000627:therapeutic use; D007612:Kanamycin / Q000627:therapeutic use; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009169:Mycobacterium tuberculosis / Q000187:drug effects / Q000254:growth & development; D011718:Pyrazinamide / Q000627:therapeutic use; D013307:Streptomycin / Q000378:metabolism*; D014376:Tuberculosis / Q000188:drug therapy
D000995:Antitubercular Agents; D011718:Pyrazinamide; D007612:Kanamycin; D004977:Ethambutol; D007538:Isoniazid; D013307:Streptomycin